Pharmaceutical composition for preventing or treating epidemic RNA viral infectious disease
AssigneeShin Poong Pharmaceutical Co., Ltd.
InventorsJei Man Ryu, Chung Ju, Hyun Kyu Chung, Geum Sil Cho
Life of this patent
Estimating the term…
Abstract
The present invention relates to a use of pyronaridine or a pharmaceutically acceptable salt thereof, and/or artemisinin or a derivative thereof for preventing or treating an epidemic RNA viral infectious disease, and more specifically, to a pharmaceutical composition for preventing or treating an epidemic RNA viral infectious disease, in particular, Coronavirus Disease 2019 (COVID-19), the composition comprising a therapeutically effective amount of pyronaridine or a pharmaceutically acceptable salt thereof, and/or artemisinin or a derivative thereof, together with a pharmaceutically acceptable carrier.
Claims15
A method for treating a respiratory disease caused by a coronavirus infection comprising:
- administering to a subject in need thereof a therapeutically effective amount of (i) pyronaridine or a pharmaceutically acceptable salt thereof, or (ii) artemisinin or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.